• 1
    Courtney DM, Kline JA. Prospective use of a clinical decision rule to identify pulmonary embolism as likely cause of outpatient cardiac arrest. Resuscitation. 2005; 65:5764.
  • 2
    Le Gal G, Righini M, Sanchez O, et al. A positive compression ultrasonography of the lower limb veins is highly predictive of pulmonary embolism on computed tomography in suspected patients. Thromb Haemost. 2006; 95:9636.
  • 3
    Wells PS, Lensing AW, Davidson BL, Prins MH, Hirsh J. Accuracy of ultrasound for the diagnosis of deep venous thrombosis in asymptomatic patients after orthopedic surgery. A meta-analysis. Ann Intern Med. 1995; 122:4753.
  • 4
    Wicki J, Perneger TV, Junod AF, Bounameaux H, Perrier A. Assessing clinical probability of pulmonary embolism in the emergency ward: a simple score. Arch Intern Med. 2001; 161:927.
  • 5
    Kearon C, Ginsberg JS, Douketis J, et al. An evaluation of D-dimer in the diagnosis of pulmonary embolism: a randomized trial. Ann Intern Med. 2006; 144:81221.
  • 6
    van Belle A, Buller HR, Huisman MV, et al. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. JAMA. 2006; 295:1729.
  • 7
    Wells PS, Anderson DR, Rodger M, et al. Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and D-dimer. Ann Intern Med. 2001; 135:98107.
  • 8
    Stein PD, Fowler SE, Goodman LR, et al. Multidetector computed tomography for acute pulmonary embolism. N Engl J Med. 2006; 354:231727.
  • 9
    Anderson DR, Kahn SR, Rodger MA, et al. Computed tomographic pulmonary angiography vs ventilation-perfusion lung scanning in patients with suspected pulmonary embolism: a randomized controlled trial. JAMA. 2007; 298:274353.
  • 10
    Righini M, Le Gal G, Aujesky D, et al. Complete venous ultrasound in outpatients with suspected pulmonary embolism. J Thromb Haemost. 2009; 7:40612.
  • 11
    Kalra MK, Maher MM, D’Souza R, Saini S. Multidetector computed tomography technology: current status and emerging developments. J Comput Assist Tomogr. 2004; 28(Suppl 1):S26.
  • 12
    Mettler FA Jr, Bhargavan M, Faulkner K, et al. Radiologic and nuclear medicine studies in the United States and worldwide: frequency, radiation dose, and comparison with other radiation sources--1950–2007. Radiology. 2009; 253:52031.
  • 13
    Brenner DJ. Radiation risks potentially associated with low-dose CT screening of adult smokers for lung cancer. Radiology. 2004; 231:4405.
  • 14
    Caro JJ, Trindade E, McGregor M. The risks of death and of severe nonfatal reactions with high- vs low-osmolality contrast media: a meta-analysis. AJR Am J Roentgenol. 1991; 156:82532.
  • 15
    Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P, Matsuura K. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology. 1990; 175:6218.
  • 16
    Mitchell A, Jones A, Tumlin J, Kline J. Contrast induced nephropathy in the emergency department setting: incidence, risk-factors and outcomes [abstract]. Acad Emerg Med. 2009; 16(Suppl 1):S21.
  • 17
    Mitchell AM, Kline JA. Contrast nephropathy following computed tomography angiography of the chest for pulmonary embolism in the emergency department. J Thromb Haemost. 2007; 5:504.
  • 18
    Kline JA, Courtney DM, Beam DM, King MC, Steuerwald M. Incidence and predictors of repeated computed tomographic pulmonary angiography in emergency department patients. Ann Emerg Med. 2009; 54:418.
  • 19
    McCullough PA, Adam A, Becker CR, et al. Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol. 2006; 98(6 Suppl 1):513.
  • 20
    Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J. 2008; 29:2276315.
  • 21
    Righini M, Le Gal G, Aujesky D, et al. Diagnosis of pulmonary embolism by multidetector CT alone or combined with venous ultrasonography of the leg: a randomised non-inferiority trial. Lancet. 2008; 371:134352.
  • 22
    Turkstra F, Kuijer PM, van Beek EJ, Brandjes DP, ten Cate JW, Buller HR. Diagnostic utility of ultrasonography of leg veins in patients suspected of having pulmonary embolism. Ann Intern Med. 1997; 126:77581.
  • 23
    Aujesky D, Smith KJ, Cornuz J, Roberts MS. Cost-effectiveness of low-molecular-weight heparin for treatment of pulmonary embolism. Chest. 2005; 128:160110.
  • 24
    Musset D, Parent F, Meyer G, et al. Diagnostic strategy for patients with suspected pulmonary embolism: a prospective multicentre outcome study. Lancet. 2002; 360:191420.
  • 25
    Mettler FA Jr, Huda W, Yoshizumi TT, Mahesh M. Effective doses in radiology and diagnostic nuclear medicine: a catalog. Radiology. 2008; 248:25463.
  • 26
    Lessler AL, Isserman JA, Agarwal R, Palevsky HI, Pines JM. Testing low-risk patients for suspected pulmonary embolism: a decision analysis. Ann Emerg Med. 2010; 55:31626.
  • 27
    Board on Radiation Effects Research. Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII, Phase 2. Washington, DC: National Academies Press, 2006.
  • 28
    Linkins LA, Choi PT, Douketis JD. Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis. Ann Intern Med. 2003; 139:893900.
  • 29
    Punthakee X, Doobay J, Anand SS. Oral-anticoagulant-related intracerebral hemorrhage. Thromb Res. 2002; 108:316.
  • 30
    Buller HR, Davidson BL, Decousus H, et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med. 2003; 349:1695702.
  • 31
    Doyle NM, Monga M. Thromboembolic disease in pregnancy. Obstet Gynecol Clin North Am. 2004; 31:31944.
  • 32
    Duriseti RS, Shachter RD, Brandeau ML. Value of quantitative D-dimer assays in identifying pulmonary embolism: implications from a sequential decision model. Acad Emerg Med. 2006; 13:75566.
  • 33
    Douketis JD, Kearon C, Bates S, Duku EK, Ginsberg JS. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA. 1998; 279:45862.
  • 34
    Almahameed A, Carman TL. Outpatient management of stable acute pulmonary embolism: proposed accelerated pathway for risk stratification. Am J Med. 2007; 120(10 Suppl 2):S1825.
  • 35
    Calder KK, Herbert M, Henderson SO. The mortality of untreated pulmonary embolism in emergency department patients. Ann Emerg Med. 2005; 45:30210.
  • 36
    Quinlan DJ, McQuillan A, Eikelboom JW. Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized, controlled trials. Ann Intern Med. 2004; 140:17583.
  • 37
    Bressollette L, Nonent M, Oger E, et al. Diagnostic accuracy of compression ultrasonography for the detection of asymptomatic deep venous thrombosis in medical patients--the TADEUS project. Thromb Haemost. 2001; 86:52933.
  • 38
    Burnside PR, Brown MD, Kline JA. Systematic review of emergency physician-performed ultrasonography for lower-extremity deep vein thrombosis. Acad Emerg Med. 2008; 15:4938.
  • 39
    Kearon C, Ginsberg JS, Hirsh J. The role of venous ultrasonography in the diagnosis of suspected deep venous thrombosis and pulmonary embolism. Ann Intern Med. 1998; 129:10449.
  • 40
    Kline JA, O’Malley PM, Tayal VS, Snead GR, Mitchell AM. Emergency clinician-performed compression ultrasonography for deep venous thrombosis of the lower extremity. Ann Emerg Med. 2008; 52:43745.
  • 41
    Frazee BW, Snoey ER, Levitt A. Emergency department compression ultrasound to diagnose proximal deep vein thrombosis. J Emerg Med. 2001; 20:10712.
  • 42
    Jacoby J, Cesta M, Axelband J, Melanson S, Heller M, Reed J. Can emergency medicine residents detect acute deep venous thrombosis with a limited, two-site ultrasound examination? J Emerg Med. 2007; 32:197200.
  • 43
    Jang T, Docherty M, Aubin C, Polites G. Resident-performed compression ultrasonography for the detection of proximal deep vein thrombosis: fast and accurate. Acad Emerg Med. 2004; 11:31922.
  • 44
    Shepard DS. Cost-effectiveness in Health and Medicine. By M.R.Gold, J.ESiegel, L.B.Russell, M.C.Weinstein (eds). New York: Oxford University Press, 1996 [book review]. J Ment Health Policy Econ. 1999; 2:9192.
  • 45
    Heron M, Hoyert DL, Murphy SL, Xu J, Kochanek KD, Tejada-Vera B. Deaths: final data for 2006. Natl Vital Stat Rep. 2009; 57:1134.
  • 46
    Pepper PV, Owens DK. Cost-effectiveness of the pneumococcal vaccine in healthy younger adults. Med Decis Making. 2002; 22(5 Suppl):S4557.
  • 47
    Tengs TO, Wallace A. One thousand health-related quality-of-life estimates. Med Care. 2000; 38:583637.
  • 48
    Das P, Ng AK, Earle CC, Mauch PM, Kuntz KM. Computed tomography screening for lung cancer in Hodgkin’s lymphoma survivors: decision analysis and cost-effectiveness analysis. Ann Oncol. 2006; 17:78593.
  • 49
    Centers of Medicare and Medicaid Services. 2009 National Physician Fee Schedule Relative Value File. Hyattville, MD: U.S. Department of Health and Human Services, 2009.
  • 50
    Centers of Medicare and Medicaid Services. Acute Inpatient PPS. Short Stay Inpatient by Diagnosis Related Group. AOR FY09 Final Notice Data. Hyattville, MD: U.S. Department of Health and Human Services, 2009.
  • 51
    Kaplan RM, Bush JW. Health-related quality of life measurement for evaluation research and policy analysis. Health Psychol. 1982; 1:6180.
  • 52
    Shiroiwa T, Sung YK, Fukuda T, Lang HC, Bae SC, Tsutani K. International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? Health Econ. 2010; 19:42237.
  • 53
    Fischer B, Lassen U, Mortensen J, et al. Preoperative staging of lung cancer with combined PET-CT. N Engl J Med. 2009; 361:329.
  • 54
    Ubel PA, Hirth RA, Chernew ME, Fendrick AM. What is the price of life and why doesn’t it increase at the rate of inflation? Arch Intern Med. 2003; 163:163741.
  • 55
    Centers of Medicare and Medicaid Services. 2009 Clinical Diagnostic Laboratory Fee Schedule. Hyattville, MD: U.S. Department of Health and Human Services, 2009.
  • 56
    Eckman MH, Rosand J, Greenberg SM, Gage BF. Cost-effectiveness of using pharmacogenetic information in warfarin dosing for patients with nonvalvular atrial fibrillation. Ann Intern Med. 2009; 150:7383.
  • 57 Warfarin sodium-coumadin, 5mg tables #30. Available at: Accessed Oct 10, 2010.
  • 58
    Kline JA, Mitchell AM, Kabrhel C, Richman PB, Courtney DM. Clinical criteria to prevent unnecessary diagnostic testing in emergency department patients with suspected pulmonary embolism. J Thromb Haemost. 2004; 2:124755.
  • 59
    Nijkeuter M, Ginsberg JS, Huisman MV. Diagnosis of deep vein thrombosis and pulmonary embolism in pregnancy: a systematic review. J Thromb Haemost. 2006; 4:496500.